ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 265 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2017. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $284,490 | -45.1% | 21,800 | -25.9% | 0.00% | -25.0% |
| Q4 2022 | $518,616 | -80.8% | 29,400 | -83.4% | 0.00% | -82.6% |
| Q3 2022 | $2,705,000 | +188.1% | 177,630 | +180.6% | 0.02% | +155.6% |
| Q2 2022 | $939,000 | +53.9% | 63,294 | +133.6% | 0.01% | +80.0% |
| Q1 2022 | $610,000 | -57.8% | 27,100 | -75.0% | 0.01% | -66.7% |
| Q3 2021 | $1,447,000 | +152.5% | 108,234 | +249.1% | 0.02% | +150.0% |
| Q2 2021 | $573,000 | +274.5% | 31,000 | +192.5% | 0.01% | +200.0% |
| Q4 2020 | $153,000 | -50.6% | 10,600 | -66.4% | 0.00% | -75.0% |
| Q4 2019 | $310,000 | +53.5% | 31,535 | +48.8% | 0.01% | +14.3% |
| Q1 2019 | $202,000 | -81.6% | 21,200 | -76.8% | 0.01% | -88.1% |
| Q2 2018 | $1,097,000 | +36.4% | 91,400 | +40.3% | 0.06% | -1.7% |
| Q1 2018 | $804,000 | +462.2% | 65,150 | +549.4% | 0.06% | +361.5% |
| Q3 2017 | $143,000 | -36.4% | 10,032 | -43.3% | 0.01% | -74.0% |
| Q2 2016 | $225,000 | – | 17,703 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 1,375,000 | $20,006,000 | 10.92% |
| Adirondack Research & Management Inc. | 574,033 | $8,352,000 | 3.28% |
| GLENHILL ADVISORS LLC | 2,461,034 | $35,808,000 | 2.64% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,949,600 | $28,367,000 | 2.42% |
| DALTON GREINER HARTMAN MAHER & CO | 2,990,902 | $43,518,000 | 2.28% |
| S&T BANK/PA | 703,223 | $10,231,000 | 1.73% |
| Tibra Equities Europe Ltd | 263,344 | $3,832,000 | 1.64% |
| Millrace Asset Group, Inc. | 116,675 | $1,697,000 | 1.63% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 1,271,450 | $18,502,000 | 1.31% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,423,223 | $137,108,000 | 1.15% |